AFMDAFMD is a successful little company with amazing med-trial results. Recommended by several “touts” as a “strong but” but apparently the market doesn’t care about their success . . . . is there something I’m missing . . . len f
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
Don’t know anything about that one — they are a very small company to have several active clinical trials, but the trials are still tiny and not all that expensive yet. Maybe the lack of interest is just because they have to keep selling shares to raise funds (they’re burning through $25 million or so per quarter, and as of May they have ~$50 million in cash).